Basic Information
ID: ALA3089581
Type: Functional
Description: Antiviral activity against Human immunodeficiency virus 1 3B infected in human CEM-SS cells assessed as inhibition of virus-induced cytopathic effect at 10 uM after 6 days by MTS assay relative to control
Organism: Human immunodeficiency virus 1
Strain: 3B
Cell type: CEM-SS
Activity Charts
Bioactivity
Activity Types for Assay ALA3089581
Inhibition
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 403.83 | 1.28 | 1.28 |
| 438.27 | 1.93 | 1.93 |
| 369.38 | 0.62 | 0.62 |
| 403.83 | 1.28 | 1.28 |
| 369.38 | 0.62 | 0.62 |
| 323.31 | -1.55 | -1.55 |
| 479.49 | 1.70 | 1.70 |
| 479.49 | 1.70 | 1.70 |
| 323.31 | -1.55 | -1.55 |
| 419.44 | 1.78 | 1.78 |
| 419.44 | 1.78 | 1.78 |
| 408.42 | 1.11 | 1.11 |
| 408.42 | 1.11 | 1.11 |
| 420.43 | 1.17 | 1.17 |
| 420.43 | 1.17 | 1.17 |
| 419.44 | 1.78 | 1.78 |
| 419.44 | 1.78 | 1.78 |
| 449.47 | 1.79 | 1.79 |
| 449.47 | 1.79 | 1.79 |
| 399.41 | 0.54 | 0.54 |
| 399.41 | 0.54 | 0.54 |
| 600.63 | 1.15 | 1.15 |
| 469.50 | 2.93 | 2.93 |
| 469.50 | 2.93 | 2.93 |
| 473.49 | 1.22 | 1.22 |
| 473.49 | 1.22 | 1.22 |
| 461.48 | 2.42 | 2.42 |
| 461.48 | 2.42 | 2.42 |
| 445.48 | 2.29 | 2.29 |
| 445.48 | 2.29 | 2.29 |
| 333.35 | -0.16 | -0.16 |
| 333.35 | -0.16 | -0.16 |
| 375.43 | 1.01 | 1.01 |
| 375.43 | 1.01 | 1.01 |
| 438.27 | 1.93 | 1.93 |
| 600.63 | 1.15 | 1.15 |
| 449.47 | 1.69 | 1.69 |
| 449.47 | 1.69 | 1.69 |
| 449.47 | 1.69 | 1.69 |
| 449.47 | 1.69 | 1.69 |
| 479.49 | 1.70 | 1.70 |
| 479.49 | 1.70 | 1.70 |